Cellebrite DI Ltd.

Cellebrite DI Ltd.

CLBT
Cellebrite DI Ltd.US flagNASDAQ Global Select
10.97
USD
+0.17
- -
2.74BMarket Cap
Cellebrite DI Ltd.
CLBT
(NASDAQ Global Select)

Recent

price

10.97

P/E

ratio

- -

div

yld

- -

ROIC.AI

2019
2020
2021
2022
2023
2024
2025
TTM
FRC
0.92
1.04
1.71
1.48
1.71
1.92
1.97
2.04
Revenue per Share
-0.05
-0.05
0.5
0.66
-0.43
-1.35
0.32
0.29
Basic EPS, GAAP
0.05
0.32
0.19
0.06
0.5
0.58
0.66
0.62
Free Cash Flow per Basic Share
0.13
0.05
0.69
- -
- -
- -
- -
- -
Dividend per Share
0.31
0.34
-0.39
0.38
0.17
1.43
1.95
2.05
Book Value per Share
0.31
0.26
-0.59
0.19
-0.02
1.26
1.14
1.05
Tangible Book Value per Share
187
187
144
183
190
209
242
244
Basic Weighted Avg Shares
172
195
246
271
325
401
476
496
Sales/Revenue/Turnover
-0.88
4.73
5.61
0.39
10.22
14.18
13.98
12.76
Operating Margin (%)
4
6
7
9
10
11
12
16
Depreciation Expense
-2
6
71
121
-81
-283
78
72
Net Income, GAAP
232.58
49.28
13.25
- -
- -
- -
13.62
15.44
Effective Tax Rate (%)
-1.09
2.97
28.99
44.63
-24.95
-70.54
16.47
14.48
Profit Margin (%)
163
165
87
88
168
272
206
191
Working Capital
- -
- -
- -
10
9
7
19
18
LT Debt
59
64
-73
74
34
336
484
511
Total Equity
- -
7.23
- -
- -
- -
- -
13.36
11.82
Return on Invested Capital (%)
- -
9.43
-1,499.08
- -
- -
- -
18.45
15.84
Return on Capital (%)
- -
-15.24
133.73
87.01
-150.08
-152.88
19.1
16.44
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
4
4
5
LT Borrowings
- -
- -
- -
LT Finance Leases
18
19
18
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
244
249
249
Market Capitalization
4,530
4,482
3,437

Working Capital

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
668
576
541
Cash, Cash Equivalents & STI
526
437
429
Accounts Receivable, Net
104
105
73
Inventories
9
8
8
Total Current Liabilities
317
370
350
Payables & Accruals
74
87
91
ST Debt
4
4
5
Deferred Revenue
240
278
255

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
91.39%
44.13%
Free Cash Flow
- -
133.53%
31.88%
Net Income, GAAP
- -
231.67%
-127.68%
Sales/Revenue/Turnover
- -
19.67%
18.56%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
90
96
107
109
401
2025
108
113
126
129
476
2026
128
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.36
-0.12
-0.99
0.08
-1.35
2025
0.07
0.08
0.08
0.09
0.32
2026
0.04
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Business
Cellebrite DI Ltd. Cellebrite DI Ltd. (Nasdaq:CLBT), founded in 1999 and headquartered in Petah Tikva, Israel, provides digital intelligence solutions for legally sanctioned investigations to law enforcement, intelligence agencies, military branches, enterprises, and corporations worldwide; operates across Europe, the Middle East, Africa, the Americas, and Asia-Pacific; offers a comprehensive Digital Intelligence platform including the flagship Cellebrite UFED for mobile device data extraction from over 30,000 devices, Pathfinder for advanced investigations and data analytics, Guardian SaaS suite for case management with new EU data-residency region and expanded Android/iOS collection via Inseyets, solutions for cloud data, social media, computers, drones, and open-source intelligence; provides training services, cybersecurity, and incident response capabilities. Cellebrite's core offerings encompass forensic extraction, review, analysis, decoding, decryption, sharing, and management of digital evidence across the investigative lifecycle for cases including child exploitation, homicide, terrorism, organized crime, human trafficking, corporate security, cryptocurrency investigations, and intellectual property theft. The company recently agreed to acquire Corellium, a developer of Arm-based virtualization software for mobile vulnerability research, DevSecOps, and virtual device testing, in a $170 million cash deal plus up to $30 million contingent consideration, expected to close in 2025; acquired Cyber Technology Services (CyTech) in 2024 to bolster U.S. federal capabilities through newly formed Cellebrite Federal Solutions with FedRAMP High pursuit and U.S. Department of Justice sponsorship; launched Autumn 2025 product releases featuring Guardian Investigate (limited production with general availability in early 2026), AWS GovCloud deployment for Pathfinder, expanded NCMEC CyberTipline integration in Inseyets for faster CSAM matching, and Corellium tooling subscriptions by defense customers in EMEA and APAC; appointed permanent CEO Thomas Hogan following interim leadership and Yossi Carmil's retirement. Cellebrite remains majority-owned by Japan-based Sun Corporation, employs over 1,100 people, and reports subscription revenue growth of 21% year-over-year in recent quarters with recurring revenue forming the bulk of its business.

Company News

APIChatGPT
  • CLBT SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Cellebrite DI Ltd.

  • CLBT SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Cellebrite DI Ltd.

  • Cellebrite DI Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Cellebrite DI (CLBT)

  • Cellebrite DI Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Cellebrite DI (CLBT)

  • Kaplan Fox Alerts Investors of Cellebrite DI Ltd. (CLBT) to an Investigation of Potential Securities Law Violations

  • Cellebrite DI Ltd. (CLBT) Q2 2026 Earnings Call Transcript

  • Shareholder Alert: Ademi LLP Investigates Claims of Securities Fraud against Cellebrite DI Ltd.

  • CLBT INVESTIGATION: Cellebrite DI Investigated for Securities Fraud by Block & Leviton; Investors Should Contact the Firm to Possibly Recover Losses

  • Cellebrite DI Q2 Earnings Call Highlights

  • Cellebrite DI Ltd. (CLBT) Q2 Earnings and Revenues Miss Estimates

  • Cellebrite Appoints Shiven Ramji Chief Executive Officer, Succeeding Thomas E. Hogan

  • Breakfast News: Abel Deploys Berkshire's Cash Pile

  • Ashford Capital Management Inc. Buys 92,092 Shares of Cellebrite DI Ltd. $CLBT

  • Cellebrite wird am 13. August 2026 die Finanzergebnisse für das zweite Quartal 2026 bekannt geben

  • Cellebrite to Report Second-Quarter 2026 Financial Results on August 13, 2026

  • Cellebrite CEO Thomas Hogan Sells 103,000 Shares for $1.6 Million: Is This a Concern for Investors?

  • Cellebrite Expands Exclusive SkySafe Partnership to Deliver Immediate Drone Detection and Airspace Intelligence for Digital Investigations at Scale

  • Cellebrite: Stronger Fundamentals Support A Buy Rating

  • Cellebrite DI Ltd. (CLBT) Discusses AI Technology and Innovation in Tech Talk Transcript

  • Cellebrite Launches the New Age of Investigations with Genesis, Now Generally Available